For the second year in a row, Fingerpaint used its creative talent and passion for giving back as an opportunity to meet the needs of hungry families across the country.
Evoke appointed industry veteran Jennifer O’Dwyer as President, North America.
Health and wellness digital agency Greater Than One hired strategic leader Andrew Bast as chief strategy officer.
Huntsworth Health appointed Helen Apostolidis as chief talent officer.
Adoption of a risk-based monitoring (RBM) approach can help enhance the safety, quality, and efficiency of clinical studies while simultaneously supporting compliance.
Whatever the final outcome of pharma’s legal fight over HHS’ price transparency rule for DTC TV, the broader challenge of providing transparency to customers who are demanding it is not going away.
Novartis has teamed up with celebrity interior designer Nate Berkus to launch My Home in Sight, a program that aims to raise awareness of the daily impact of wet age-related macular degeneration and empower those living with wet AMD and their caregivers to make simple, functional changes to support safety and independence at home.
Hospitals are continuing to charge, on average, five times their cost for medicines, according to a study by The Moran Company commissioned by PhRMA.
With the decision of CEO Olivier Brandicourt to retire, Sanofi’s board chose Paul Hudson as his successor.
Christi L. Shaw will join Gilead Sciences Inc.’s subsidiary Kite as CEO and she will also become a member of Gilead’s senior leadership team.
